Evidence map›Paper›PMID 39094987›Full record

ArticlePharmacological research2024

Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation.

Yuan Gao, Julian Kwan, Joseph Orofino, Giulia Burrone, Sahana Mitra, Ting-Yu Fan, Justin English, Ryan Hekman, Andrew Emili, Shawn M Lyons and 2 more

Abstract read
In one paragraph

Article in Pharmacological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Covalent inhibition ofiScience · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuan GaoDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Julian KwanDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States; Center for Network and Systems Biology, Boston University, Boston, MA 02115, United States.
Joseph OrofinoDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Giulia BurroneDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States; Department of Computer Science, University of Torino, Torino, Italy; Department of Clinical and Biological Science, University of Torino, Torino, Italy; Graduate Program in Complex Systems for Quantitative Biomedicine, University of Torino, Torino, Italy.
Sahana MitraDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Ting-Yu FanDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Justin EnglishDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States; Graduate Program in Pharmacology and Experimental Therapeutics, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Ryan HekmanDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States; Center for Network and Systems Biology, Boston University, Boston, MA 02115, United States.
Andrew EmiliDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States; Center for Network and Systems Biology, Boston University, Boston, MA 02115, United States; Biology Department, Boston University, Boston, MA 02115, United States.
Shawn M LyonsDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Maria Dafne CardamoneDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States.
Valentina PerissiDepartment of Biochemistry and Cell Biology, Chobanian&Avedisian School of Medicine, Boston University, Boston, MA 02115, United States. Electronic address: vperissi@bu.edu.

Funding

Regulation of Ribosome BiogenesisR35GM146769 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Shawn M Lyons · 2022 to 2026
$2.0M
Regulation of mitochondrial homeostasis through retrograde signalingR01GM127625 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERISSI, VALENTINA · 2018 to 2021
$1.8M
Coordination of PAR and Ub signaling in mitochondriaR35GM149339 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VALENTINA PERISSI · 2023 to 2026
$1.8M
Regulation of Ribosome Biogenesis During StressR00GM124458 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LYONS, SHAWN M · 2020 to 2022
$734k
NIGMS NIH HHS R00 GM124458NIGMS NIH HHS R01 GM127625NIGMS NIH HHS R35 GM146769NIGMS NIH HHS R35 GM149339
6 · The paper itself

Abstract

G-Protein Pathway Suppressor 2 (GPS2) is an inhibitor of non-proteolytic K63 ubiquitination mediated by the E2 ubiquitin-conjugating enzyme Ubc13. Previous studies have associated GPS2-mediated restriction of ubiquitination with the regulation of insulin signaling, inflammatory responses and mitochondria-nuclear communication across different tissues and cell types. However, a detailed understanding of the targets of GPS2/Ubc13 activity is lacking. Here, we have dissected the GPS2-regulated K63 ubiquitome in mouse embryonic fibroblasts and human breast cancer cells, unexpectedly finding an enrichment for proteins involved in RNA binding and translation on the outer mitochondrial membrane. Validation of selected targets of GPS2-mediated regulation, including the RNA-binding protein PABPC1 and translation factors RPS1, RACK1 and eIF3M, revealed a mitochondrial-specific strategy for regulating the translation of nuclear-encoded mitochondrial proteins via non-proteolytic ubiquitination. Removal of GPS2-mediated inhibition, either via genetic deletion or stress-induced nuclear translocation, promotes the import-coupled translation of selected mRNAs leading to the increased expression of an adaptive antioxidant program. In light of GPS2 role in nuclear-mitochondria communication, these findings reveal an exquisite regulatory network for modulating mitochondrial gene expression through spatially coordinated transcription and translation.

Indexed as

MitochondriaProtein BiosynthesisUbiquitinationAnimalsCell Line, TumorHumansIntracellular Signaling Peptides and ProteinsMiceMitochondrial ProteinsUbiquitin-Conjugating EnzymesGPS2 protein, humanGPS2 protein, mouseIntracellular Signaling Peptides and ProteinsMitochondrial ProteinsUbiquitin-Conjugating EnzymesFCCPGPS2Homo-harringtonineMitochondriaMitochondria stress response (MSR)NSC697923PABPC1PuromycinTamoxifenTranslationUbiquitin

Identifiers

PMID39094987
PMCPMC11905147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.